At a state of obesity and insulin resistance, levels of fasting IGFBP1 were significantly reduced and this functioned as a predictive biomarker for developing abnormal glucose regulation [41]. This evidence concerns the gene IGFBP1 and obesity due to melanocortin 4 receptor deficiency.